Pediatric Heart Transplantation: Transitioning to Adult Care (TRANSIT): Feasibility of a Pilot Randomized Controlled Trial
Overview
Authors
Affiliations
Background: Young-adult heart transplant recipients transferring to adult care are at risk for poor health outcomes. We conducted a pilot randomized controlled trial to determine the feasibility of and to test a transition intervention for young adults who underwent heart transplantation as children and then transferred to adult care.
Methods: Participants were randomized to the transition intervention (4 months long, focused on heart-transplant knowledge, self-care, self-advocacy, and social support) or usual care. Self-report questionnaires and medical records data were collected at baseline and 3 and 6 months after the initial adult clinic visit. Longitudinal analyses comparing outcomes over time were performed using generalized estimating equations and linear mixed models.
Results: Transfer to adult care was successful and feasible (ie, excellent participation rates). The average patient standard deviation of mean tacrolimus levels was similar over time in both study arms and < 2.5, indicating adequate adherence. There were no between-group or within-group differences in percentage of tacrolimus bioassays within target range (> 50%). Average overall adherence to treatment was similarly good in both groups. Rates of appointment keeping through 6 months after transfer declined over time in both groups.
Conclusions: The feasibility of the study was demonstrated. Our transition intervention did not improve outcomes.
Health care transition planning and outcomes: What's next?.
Betz C, Diaz-Gonzalez de Ferris M Health Care Transit. 2024; 2:100045.
PMID: 39712591 PMC: 11657942. DOI: 10.1016/j.hctj.2024.100045.
Patient navigator programmes for children and adolescents with chronic diseases.
Lalji R, Koh L, Francis A, Khalid R, Guha C, Johnson D Cochrane Database Syst Rev. 2024; 10:CD014688.
PMID: 39382077 PMC: 11462635. DOI: 10.1002/14651858.CD014688.pub2.
Peterson C, Bitterfeld L Pediatr Nephrol. 2024; 40(1):223-230.
PMID: 39240281 DOI: 10.1007/s00467-024-06497-0.
Shemesh E, Duncan-Park S, Mazariegos G, Annunziato R, Anand R, Reyes-Mugica M Clin Trials. 2023; 20(5):528-535.
PMID: 37269062 PMC: 10524899. DOI: 10.1177/17407745231176834.
Kato T, Gomi H, Aizawa Y, Kawamura A, Eisen H, Hunt S Front Pediatr. 2022; 10:935167.
PMID: 36405837 PMC: 9671939. DOI: 10.3389/fped.2022.935167.